Jefferies Initiates Pfizer With Overweight
Analysts at Jefferies initiated coverage on Pfizer Inc. (NYSE: PFE) with a Overweight rating.
The target price for Pfizer is set to $45.
Pfizer shares have gained 14.57 percent over the past 52 weeks, while the S&P 500 index has surged 7.12 percent in the same period.
Pfizer shares rose 0.06 percent to close at $34.06 yesterday.
Latest Ratings for PFE
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.